Stay updated with breaking news from Icahn School. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As “Alzheimer’s and Brain Awareness Month” approaches, in June, we should consider the complexity of human cognition. George Naasan, M.D., Associate Professor of Neurology at Icahn School of Medicine, outlined
Researchers at the Icahn School of Medicine at Mount Sinai have made a significant breakthrough in Alzheimer's disease research by identifying a novel way to potentially slow down or even halt disease progression. The study, which focuses on the role of reactive astrocytes and the plexin-B1 protein in Alzheimer's pathophysiology, provides crucial insights into brain cell communication and opens the door to innovative treatment strategies. It was published in Nature Neuroscience on May 27.
Human-Centric Lighting (HCL) conversations should take into consideration combining circadian lighting, aesthetics, and motorized shades.
Researchers have found a new way to potentially slow or stop Alzheimer's disease. Their study shows that the plexin-B1 protein and reactive astrocytes (a
Researchers at the Icahn School of Medicine at Mount Sinai have made a significant breakthrough in Alzheimer's disease research by identifying a novel way to potentially slow down or even halt disease progression.